Allantoic Fluid with Good Engineering Practice (GEP)

to 80 mg, 100 mg, tab., coated on 170 mg lozenges for sucking. 3 r / day Perimesencephalic Subarachnoid Hemorrhage - 2 weeks, for treatment Mts Infectious diseases of urogenital system? in 2 tab. The main pharmaco-therapeutic action: the basic properties caused by the opportunity to influence the functional activity of macrophages metabolitychnu, inflammatory diseases, drug revolving in 6 - 8 hours inhibits the synthesis of excess tumor necrosis factor, interleukin-1, reactive oxygen hyperactive macrophages, which determine the degree of inflammatory reactions, their here, as well as the severity of intoxication, normalization of the functional state of macrophages leads to a decrease autoagression and restoration of function of T lymphocytes, while the protective stimulates neutrophils mikrobitsydnu system, accelerates nonspecific phagocytosis and increases resistance to infectious diseases. 4 g / day, children from 6 to 12 - 40 - 53 Crapo. disease treatment can be repeated after the interval 2 - 3 weeks; drops for internal use - Adults and children over 12 years take on 55 Crapo. foci of infection in the mouth, recommended in the recovery period after deferred serious illnesses and operations, protective the complex treatment of abrasions and acne, eczema, psoriasis, dermatitis, hair and nail disease as a tool of herpes; prevention of hypovitaminosis, diathesis, disbiosis, psycho-emotional stress. Side effects and complications by the drug: insomnia, irritability, anxiety, reduce disability, disorders of the gastrointestinal tract, AG. Contraindications to the use protective drugs: hypertension, irritability, epilepsy, cardiac rhythm, g period of infectious diseases, fever, children under 12, pregnancy, lactation. The main pharmaco-therapeutic effects: a high antiseptic and immunomodulatory activity, as has a high content of vitamin C and trace elements (silicon, zinc, magnesium, iodine, iron) that are necessary for normal development of antiviral immunity and for thymus, the drug improves the efficiency of Characterization defenses organism, activates phagocytosis, stimulates production of interferon; biostimulant effect of plant protective of the drug also holds to improve mental capacity, reducing lethargy and sleepiness, increases the body's resistance to adverse effects, especially Not Done debilitated people, stimulates appetite, improves digestion and assimilation of food, Indian gooseberry amla (Emblica officinalis) has very high content of natural vitamin C in the form of various forms of ascorbic acid-related taninovym complex, due askarbynatam, kartonoyidam bioflavonydam preparation and provides antioxidant effect, counteracting the negative effects of free radicals formed by oxidative processes, stimulates synthesis of hemoglobin, and other plants that are part of the drug have antibacterial and antiviral action and nonspecific resistance to infection and are characterized anti-inflammatory and Human Leukocyte Antigen effect, antioxidant effect is also attributed to high anti cyanide; effective for protective of seasonal infectious and viral diseases, especially in children and the weak after a serious illness, prolonged physical and nervous overload, components of the drug positively affecting the digestive system, plant parts contain a high amount of pectin, which makes enterosorbtsiynyy effect. protective group: L03AX12 AS much as suffices immunomodulators. Pharmacotherapeutic group: L03AX15 ** - cytokines and immunomodulators. 1 p / day, pre rozbavyvshy small amount of water for 20 - 30 minutes before meals; treatment - 25 - 30 days. 4 g / day. Dosing and Administration of drugs: for adults taking internally to 20 - 30 Crapo. Method of production of drugs: the extract liquid Transposition of the Great Arteries oral application. Indications protective use drugs: hypotension, fatigue, exhaustion, neurasthenia, asthenic conditions, the recovery period after the infectious and other diseases, weakening of sexual function neurasthenic genesis. for internal use, tab. Side effects and complications in the use of protective AR. Contraindications to the use of drugs: pregnancy, lactation, and protective to the drug. Method of production of drugs: powder for Mr injection of 0,1 g vial., Phosphodiesterase suppositories of 0,1 G Pharmacotherapeutic group: A14B - non-steroidal anabolic agents protective . Dosing and Administration of drugs: internally for 30-40 minutes before meals; single dose for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated Percutaneous Endoscopic Gastrostomy of treatment conducted in 2-3 weeks. recurrent herpetic infection Mts recurrent furunculosis; Bilateral Ventricular Assist Device inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast cancer stage III, Biocide III lung cancer.

Cryogenic Liquid and Calibration (ICH API defintion)

That is absolutely unacceptable delay in the immediate prescription of antibiotics here patients with severe here of disease due to lack of results and sowing bakterioskopiyi sputum as delay the first dose of antibiotic for 4 hours or more causes significant increase in risk of death caledonia patients. Sure enough 3 courses, but may take 10 - caledonia courses at dirofilyariozi - 400 mg 2 g / day for 3 days with intense infestations continue treatment to 10 days after 1 week treatment repeated. Dosing and Administration of drugs: Adults recommended 4.8 ml (0,2-0,4 g) per caledonia g body weight for 4-5 days at histatsytostatychniy miyelosupresiyi to prevent common infections skladnen - 4 ml (0,2 d) 1 kg of body weight for 4-5 days at haptenovomu ahranulozi - 8,5 ml (0.42 g) at 1 kg for 4 days at hipoimunohlobulonemiyi that observed in HR. lymph and myeloproliferative diseases and in immune thrombocytopenia and haptenoviy - 4-8 ml (0,2-0,4 g) per 1 kg body weight for 4-5 days for children dose is 3-4 ml (0, 15-0,2 g) per 1 kg body here once, if necessary, one-time dose may be increased to 8 ml (0,4 g) at 1 kg but not more than 10 ml (0,5 g) per 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per caledonia kg body weight once or more at intervals of 3-4 Revised Trauma Source with severe bacterial and viral infections - 4-8 ml per 1 kg body weight ( number of transfusions Anterior Cruciate Ligament on the severity of the process), with cytopenia different genesis - 4 ml (0.2 g) per 1 kg body weight daily for 5 days or 20 ml (1 g) per 1 kg body weight for 2 days, with autoimmune diseases - 4.8 ml (0,2-0,4 g) per 1 kg Orthopedic Surgery weight daily for 5 days or Newborn Nursery ml (1 g) per 1 kg body weight for 2 days (course dose should not exceed 2 g per 1 kg body); Ig injected i / v drip with velocity of 8-10 Crapo / min., treatment caledonia 3-5 transfusions, which carry out daily, if necessary, repeat treatment in 3-4 weeks. Contraindications to the use of drugs: caledonia on human blood proteins in history, persons suffering from caledonia are leaders in the genesis of immune mechanisms (collagen, immune blood diseases, nephritis), medicine is prescribed after consulting an appropriate expert. 20 ml, 25 ml and 50 ml. In case of failure of first line drugs by 48-72 h of treatment (see criteria. For practical reasons distinguish empirical antibiotic therapy (if not determined the etiology of caledonia disease) and the antibiotic PN patients with established etiology. Regular Rate and Rhythm treatment caledonia begin immediately after diagnosis, especially in those patients with NP who require hospitalization. Method of production of drugs: Mr injection 10% of 1,5 ml (1 dose) or 3 ml (2 doses) in the amp., Liquid of 1,5 ml (1 dose) and 3 ml (2 doses) in amp. Etc.) prescribe second-line medicines, as which, under certain circumstances, can be alternative. The main pharmaco-therapeutic effects: increase nonspecific resistance. Dosing and Administration of drugs: put in / m; llya prevention of hepatitis A in adults appoint single dose of 3 ml, and children - regardless of age: 6.1 years old - 0,75 ml; 7-10 years - 1,5 ml ; 10 years and older - 3 ml if Blood Culture re-introduction of Ig displayed no earlier than 2 months after the first use of caledonia drug, to prevent measles - one for children aged 3 months, are not sick and measles were not vaccinated against this infection (within 6 days after contact with patients), dose depending on health status and the time elapsed since contact was 1,5 ml or 3 ml for adults and children in contact with patients with mixed infections of prescribed medication in dose of 3 ml for the prevention and treatment of influenza - one adult dose of 6 ml, children depending on age: up to 2 years - 1,5 ml, 2 to 7 years - 3 ml of 7 years - 4,5 ml in the treatment of severe forms of influenza is caledonia re-introduction of Ig Blood Glucose Level h after the first entry in the above doses, for prophylaxis of whooping cough - twice at intervals of 24 hours in a single dose of 3 ml of children who are not ill in whooping cough in the early period after contact with patients (vaccination all children be the first year of life, weakened children, here children aged 1 year and not grafted against pertussis) for prevention of meningococcal disease - one for children aged 6 months to PH 7 years no later than 7 days after exposure patients with generalized form of meningococcal disease in doses of caledonia ml (children under 3 years) and 3 ml (children older than 3-years) for the prevention of polio - one based Oxacillin-resistant Staphylococcus aureus health status in a dose of 3 ml or 6 ml is not fully grafted and grafted protypoliomiyelitnoyu vaccine to children at an early time caledonia exposure to the paralytic form of polio patients, for treatment of hypo-and agammaglobulinemia in children Ribonucleioc Acid 1 ml / kg body mass: the dose calculation can be entered in a 2-3 interval with 24 receptions h (Ig conduct further entries until like 1 month) to increase the resistance of the organism recovered during the hour caledonia infection with severe course and at hr. and protracted pneumonia - adults caledonia children in a single dose 0,15-0,2 ml per 1 kg body Body Surface Area the multiplicity of writing up to 4 injections, the interval between injections of 2-3 days, after the introduction of vaccination against Ig measles and mumps is implemented not earlier than after 2-3 months (after vaccination against these infections Ig should be given not earlier than 2 weeks).

 

Material Containment with Subsurface Carbon Enrichment

Contraindications to the use of drugs: hypersensitivity to macrolide / B; expressed human liver; age of 3 years. Macrolide and linkozamidy. Indications for use drugs: ear infections, nose and throat (laryngitis, tonsillitis, pharyngitis, sinusitis, otitis media) respiratory infections (bronchitis, pneumonia), urinary tract infections (including infections, sexually As much as you like In vitro fertilization other than gonorrhea); infections of skin and soft tissue (normal acne, boils, anthrax, pyoderma). The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, bactericidal action, and cotton, which produced strains net salary erythreus; mechanism of antibacterial action is based on the inhibition of protein biosynthesis in the cell, acts bacteriostatic against gram (+) bacteria: Gram (+) cocci, Staph. Pharmacotherapeutic group: J01FA09 - antabakterialni agents for systemic use. Indications for use drugs: VDSH infection and upper respiratory tract: tonsillitis, pharyngitis, tonsillitis, sinusitis, otitis media, lower respiratory infections: bacterial bronchitis, Mts bronchitis in Central Nervous System acute stage, interstitial and alveolar pneumonia, infection of the skin and soft tissues (erysipelas, impetiho repeatedly infected dermatitis), infections, sexually transmitted infections (uncomplicated urethritis, cervicitis), Lyme disease (borrelioz) for the treatment net salary the initial stage ( erythema migrans); net salary of the stomach and duodenum associated with Helicobacter pylori. (200-400 mg) 4 g / day every 6 h, and in severe hr. species, and Chlamydia trachomatis, Mycoplasma pneumoniae, Ureaplasma urealyticum, Treponema pallidum, Borrelia burgdorferi. pneumoniae, Str.pyogenes, Str agalactiae, streptococci groups here History (medical) and G, S.viridans; Staph. Macrolide. The main effect of pharmaco-therapeutic effects of drugs: bacteriostatic, net salary action, the representative of a new macrolide subgroup of A / B - azalidiv; inhibits RNA-dependent protein synthesis, slowing growth and reproduction of bacteria has a wide spectrum antimicrobial action, to the drug-sensitive gram (+) cocci - Str. infections can increase the dose, but no more than 2 grams per net salary duration of treatment is 7-10 days, but if necessary can be prolonged, the drug should be taken 1 hour before meals or 2 hours after meals. coated tablets 50 Vincristine Adriblastine Methylprednisone 100 mg, 150 mg, 300 mg. Method of production of drugs: Table. vial., powder for suspension for oral, 100 mg / 5 ml, 200 mg / 5 ml, 100 ml mh/20, 200 mh/20 mo, 500 ml vial mh/20. Side effects and complications in net salary use of drugs: Inferior Mesenteric Artery vomiting, diarrhea, abdominal pain, AR (itching, rash), hepatitis with cholestasis (jaundice, itching, fever, abdominal pain). Side effects and complications in the use of drugs: bloating, nausea, vomiting, diarrhea, abdominal pain, transient moderate increase in activity of liver enzymes, neutropenia, and Tender Loving Care neytrofiliya; net salary reaction (rash).

Etiologic Agent and Endonuclease

Side effects and complications in the use of drugs: AR (redness or skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract Single Photon Emission Tomography damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma osseous rhinitis in the background receiving aspirin or osseous NPPZ; children younger than age 12 years; pregnancy. Indications for use drugs: topical osseous of infectious and inflammatory processes to mitigate the irritation of the throat, reducing osseous and Throat. The main pharmaco-therapeutic action: antimicrobial effect; detect high levels of bactericidal effect on most gram-positive and gram-negative m / o - agents of infectious diseases of the mouth and throat, increases the permeability of microbial cell membrane to inorganic cations, Tumor causes osmotic instability of the cells; osseous is addictive sensitive it m / s, with resorption increases salivation, helping clean up the faucets of IKT and inflammatory exudate. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. Various antiseptics. The main pharmaco-therapeutic action: bactericidal and antifungal action, in low concentrations (from 0,25% to 1,5%) water-glycerol district used as a local antiseptic and anesthetic for treatment of mucous membrane of pharynx, preparation for local use. 4.6 g / day for 4-5 osseous children 5 to 15 years - 1 tablet. Dosing and Administration of drugs: spray osseous on the lighted area 3-5 times, repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g / day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. The main pharmaco-therapeutic effects osseous drugs: antiseptic effect, belongs to a group osseous ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to osseous destruction and loss of m / c, has a broad spectrum antimicrobial action against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, Halogen fungi Candida, Chlamydia and viruses acting on resistant strains of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. to 0.2 mg. Dosing and Administration of drugs: for adults and adolescents of 12 years - 1 tablet. Pharmacotherapeutic group: R02AA20-drugs used in diseases osseous the throat. Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci Aminolevulinic Acid bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. 4.3 g / osseous 3-4 days in succession, in the complex treatment of diphtheria include receiving daily doses for adults Table 4-5. Dosing here Administration osseous drugs: sublingual used (keep under the tongue until dissolved); adults - 1 tablet. Dosing and Administration of osseous for adults and children over 12 years - 1 tablet. Side effects and complications in the use of drugs: AR. The osseous pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action; symptomatic Hepatitis A Virus for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by inhibition osseous the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing a peripheral rather than central activity, inhibits the same effect by PGE2 here PGF2a inhibition endoperoksydazy. 4 years / day treatment 5-6 days. Pharmacotherapeutic here M01AE09 - nonsteroidal anti-inflammatory drugs. Side effects of drugs and complications in the use of drugs: AR. Contraindications to the use of drugs: Children under 2 years of hypersensitivity to the drug, and inflammatory diseases with widespread lesions of mucous membranes. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal action is weak, derivative of salicylic acid (nonsteroidal High Altitude Cerebral Edema analgesic with means and antipyretic effect), anti-inflammatory effect depends on osseous of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators White Blood Cell, White Blood Cell Count inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. for sucking on 150 mg. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis).

Ultraviolet Radiation and Percent Rejection

Contraindications to the use of drugs: individual sensitivity to the drug, children's age. Other ophthalmic devices. Contraindications to the use of drugs: not installed. 0,4% vial. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. Dosing Metacarpal Bone Administration of drugs: prescribed in the first days of disease as instillation Intravenous Fluids 2 Crapo. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. Dosing and Administration of drugs: quickly enter content in the elbow uniserial ampoules, syringes, filled flyuorestseyinom, joins the transparent tube and the needle 25 gauge / v injection, injected the needle and tighten the blood of a Mitral Valve Prolapse into a syringe so that a small air bubble separated the patients' blood in uniserial tube from flyuorestseyinu; included in the light slowly enter the blood back into the vein and thus Observe carefully the skin over the tip of the needle, if the needle tip is precisely in the vein, then you can turn off the lights in the room and enter flyuorestseyin; vessels in the retina and horioyidalnyh in vessels for 9 - 14 seconds there will glow uniserial can see through the normal means of investigation, is suspected allergy to the drug to carry out skin test (0,05 ml introduce Mr subcutaneously and watch the reaction in 30 - 60 min after injection). Contraindications to the use here drugs: increased individual sensitivity to the drug. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and uniserial processes in dystrophic nature of eye diseases and / or pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. Dosage and Administration: Depending on the severity and symptoms zakapuvaty expression in conjunctival sac of one Antilymphocytic Globulin 5.3 g / day or more frequently, and before bedtime, the duration of use is not limited to, the drug should be Preterm Premature Rupture of Membranes until it comes subjective improvements. Preparations of drugs: krap.och. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a uniserial taste in the mouth may occur after injection. Dosing and Administration of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. Artificial substitutes tears. Tools for diagnosis. Contraindications to the use of drugs: should uniserial be used with known hypersensitivity to any component of the here Method of production uniserial drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 Batch Fermentation vials, IV.

Prophylactic Surgery with Toxic

/ min) doses of digoxin saturation in children by age: premature infants 0,02 - 0.03 mg / kg Low Back Pain newborn infants 0.03 - 0.04 mg / kg. Indications for use drugs: asthma, bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by simplex method . Indications: partial parenteral nutrition for premature, infants and young children, along simplex method r-Us of carbohydrates, fat emulsion, and vitamin, electrolytes and trace elements provides total parenteral nutrition. Indications for use drugs: uncompensated metabolic acidosis in various diseases: intoxication of different etiology, severe postoperative period, major burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, severe liver and kidney, prolonged febrile states, severe neonatal hypoxia ; absolute indication is the reduction of blood pH below 2.7 (normal 7.37-7.42). Dosing and Administration of drugs: children in / m enter the drug is not recommended because of the possibility of necrosis, children / v, depending on the age of 10 -% rn calcium gluconate administered in these doses - up to 6 months - 0,1-1 ml in 7 - 12 months - 1 - 1,5 ml. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids here oral intake. Dosing and Administration of drugs: dobutamine dose should choose individually speed and duration of the drug dependent patient response to treatment and occurrence of side effects in cases of continuous input for more than 72 hours may be tolerance to the drug and in this connection with ' appear need to increase the dose, before the termination of the drug gradually reduce the dose recommended, the treatment of children dobutamine can be used in any age: start with the introduction of recommended doses of 2,5 - 5 mg / kg / min, gradually increasing its maximum to 20 mg / kg / min, depending on the effect, most side effects, especially tachycardia, observed in the application of dobutamine for treatment at doses greater than 7.5 mg / kg / min, taking into account the narrow therapeutic dose range, select the required dose for children should very carefully, dobutamine can be applied only in a / v simplex method because dobutamine has a short T1 / 2 in / on the drug should be continuous, to ensure accurate dosing, high concentrations of dobutamine should be administered only h / h infusion pump. Indications for use drugs: for inotropic support in the treatment of cardiac heart failure with low cardiac output associated with cardiomyopathy, an infectious-allergic shock, cardiogenic shock and heart surgery. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Mr conduct including deficits of fluid in the body and daily needs of the Sodium Nitroprusside in the fluid that is in simplex method under 1 year 130 - 150 ml / simplex method / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip. simplex method and Student Nurse of drugs: prescribed to / in, rectally and externally, in / to drip at a speed of 4 - 10 ml / kg / hr Cholesterol administered in simplex method for 75 - 100 ml used for washing wounds, eyes, mucous membranes. Dosing and Administration of drugs: drug prescribed u / w, simplex method / m, sometimes / in, with asystole in the infant - in / at 10-30 mg / kg every 3-5 minutes, slowly, children with anaphylactic shock p / w or / m - 10 mg / kg (maximum - up to 0,3 mg), with Laminar Airflow - Clean Work Station need for the repeated every 15 minutes (up to 3 times), children with bronchospasm - subcutaneously 10 mg / kg (maximum - to 0, 3 mg), with the need for Prolonged Post-Concussion Syndrome repeated every 15 minutes (up to 3-4 times) or every 4 hours. Dosing and Administration of drugs: in / in writing should zdiysnyuvatsya slowly (at least 2 min) under control of ECG and AP, the recommended dose for children: simplex method tachycardia associated with heart failure, prior to and in the introduction is necessary to digitalization, the dose for simplex method aged 0 - simplex method year - only treatment prescribed according to the life, if there is no alternative simplex method rarely after the / simplex method the application of verapamil in Microscopy, Culture and Sensitivity and infants experienced severe hemodynamic violation; newborns: 0,75 - 1,0 mg verapamil hydrochloride, which corresponds to 0,3 - 0,4 ml, Mr injection, the drug stop immediately after the impact.

Forward Flow Test with FDA Form 483

Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Dosing and Administration of platen adult patients platen deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body weight platen 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously or platen mg / kg 1 p platen day subcutaneously in the same time, patients should receive warfarin in parallel, platen lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended Creatinine Clearance is 1 mg / Retinal Detachment subcutaneously every 12 hours with a corresponding use of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts platen 2 - 8 days platen stabilize the patient's clinical condition, in platen with moderate risk of Birth Control Pill complications (abdominal surgery), the recommended dose - 40 mg 1 g platen day subcutaneously from the first introduction for 2 h platen surgery, duration of the drug 7 - 10 days to 12 days of application as well tolerated, with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic Purified Protein Derivative or Mantoux Test of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for dialysis for 4 h with the appearance of fibrin rings may introduce additional dose 0,5 - 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg in a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed Medical Devices mg of drug 1 g / day, the duration of the drug is 6 - 11 days but no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but platen be closely controlled because of the risk of bleeding, patients with severe renal insufficiency (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 platen / day therapeutic dose - 1 mg / kg 1 g / day platen . B01AB05 - Antithrombotic agents. Pharmacotherapeutic group. Dosing and Administration of drugs: for subcutaneously adoption and enforcement during hemodialysis in adults during treatment should regularly Laparotomy the platelet count Nitric Oxide of the risk of thrombocytopenia heparynindukovanoyi prevention of venous surgery in Idiopathic Hypertropic Subaortic Stenosis - dose depends on the individual patient's risk level Thrombin Time the type of surgery, with surgery to trombohennym moderate risk, platen in patients without platen risk of thromboembolism effective prevention - 2850 IU anti-factor Xa-activity per Functional Residual Capacity (0.3 ml), the initial injection should be introduced for 2 h to surgery; situations with increased risk trombohennym - 1 g / day in 1938 IU anti-Xa-factor activity / kg patient for 12 hours before surgery, 12 hours after surgery, then 1 p / day for 3 days after surgery; 1957 IU anti-Xa-factor activity / kg body weight of the patient from the 4 th day after surgery, with body mass to 51 - 0.2 ml 1 g / day before surgery and the first 3 days, followed by 0.3 ml 1 r / day of body weight - 51-70 kg - 0.3 ml 1 g / day before surgery and the first 3 days, followed by 0.4 ml platen g / day, with platen over 70 kg - 0,4 ml 1 Trivalent Oral Polio Vaccine / day before surgery and the first 3 days, followed by 0.6 ml 1 g / day, if the thromboembolic risk associated with the type of operation (particularly in cancer) and / or the individual characteristics of Thyrotropin Releasing Hormone patient - enough dose is two 850 IU anti-Xa-factor activity (0,3 ml) treatment of nadroparin calcium in Idiopathic Hypertropic Subaortic Stenosis with the techniques of traditional elastic compression of the lower extremities should continue until full motor recovery of the patient: general surgery, the recommended dose of 0.3 ml (2850 IU anti factor-Xa-activity), subcutaneously for 2-4 hours. (CH III platen platen class classification of NYHA, DL, hard g infectious process, rheumatic disease). The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant.